RESOLUTE INTEGRITY RX
Report
- Report Number
- 9612164-2018-00109
- Event Type
- Death
- Date Received
- January 20, 2018
- Date of Event
- January 1, 2015
- Report Date
- January 22, 2018
- Manufacturer
- MEDTRONIC IRELAND
- Product Code
- NIQ
- PMA / PMN Number
- P110013
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- SZ
- Reporter Occupation
- OTHER
Narratives
CORRECTION: INITIAL MDR SUBMITTED WITH INCORRECT PMA # P030009 REFERENCED INSTEAD OF PMA # P110013. IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.
COMBINATION PRODUCT NOT SELECTED IN INITIAL MDR. IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.
JOURNAL NAME: JOURNAL OF CARDIOVASCULAR MEDICINE AUTHORS: MILOSZ JAGUSZEWSKIA,_, JELENA-RIMA GHADRIA,_, BURKHARDT SEIFERTB, THIERRY HIESTANDA, PAOLA HERRERAA, OLIVER GAEMPERLIA, ULF LANDMESSERA, WILLIBALD MAIERA, BRAHMAJEE K. NALLAMOTHUC, STEPHAN WINDECKERD, THOMAS F. LU¨ SCHERA AND CHRISTIAN TEMPLINA. TITLE OF ARTICLE: DRUG-ELUTING STENTS VS. BARE METAL STENTS IN PATIENTS WITH CARDIOGENIC SHOCK: A COMPARISON BY PROPENSITY SCORE ANALYSIS. LITERATURE REFERENCE: DOI:10.2459/(B)(4) YEAR: 2015 ISSUE #:16. IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.
REPORTED FROM JOURNAL ARTICLE. THE AUTHORS SOUGHT TO ASSESS THE PERFORMANCE OF DRUG-ELUTING STENTS (DES) COMPARED WITH BARE METAL STENTS (BMS) AMONG PATIENTS WITH CARDIOGENIC SHOCK UNDERGOING PERCUTANEOUS CORONARY INTERVENTION (PCI). 203 PATIENTS WERE INCLUDED IN THE FINAL ANALYSIS. DES INCLUDED ZOTAROLIMUS-ELUTING STENTS. BMS INCLUDED SKYLOR AND DRIVER STENTS. CULPRIT LESIONS WERE LOCATED IN THE LEFT MAIN, LAD, LCX, RCA AND BYPASS VESSELS. PATIENT OUTCOMES INCLUDED DEATH, MYOCARDIAL INFARCTION, ANY REPEAT REVASCULARIZATION AND STROKE.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 52129 | RESOLUTE INTEGRITY RX | STENT, CORONARY, DRUG-ELUTING | NIQ | MEDTRONIC IRELAND |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 64 YR | Death| R |